Executive Medical Director
Providence Cancer Institute
Portland, OR, United States
R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) is Executive Medical Director of the Providence Cancer Institute, Member and Director of the Earle A. Chiles Research Institute and the Walter J. Urba Chair for Cancer Research in Portland, Oregon. In these roles, he oversees oncology services and research teams that deliver care to more than 9,000 cancer patients annually in 32 clinics and 8 Oregon hospitals. As an internationally recognized head and neck surgeon, Bell has led pioneering research and clinical efforts to integrate immunotherapy into the neoadjuvant setting. Using his surgical practice to conduct clinical trials, Bell’s research bridges basic, translational and clinical activities. In addition, he has worked to develop technologically advanced methods to enhance the effectiveness of head and neck cancer surgery, including virtual surgical planning, transoral robotic surgery and sentinel lymph node biopsy. His work has been published in more than 250 scientific articles and book chapters and he is co-author of two major textbooks, including "Oral, Head and Neck Oncology and Reconstructive Surgery". A previous fellowship director, he has trained dozens of residents and fellows in head and neck oncologic and reconstructive surgery. Bell has served on National Institutes of Health Head and Neck Steering Committee’s Immunotherapy Clinical Trials Planning Group and the Task Force on Previously Untreated/Locally Advanced (PULA) Disease. He has held numerous leadership positions within various professional and non-profit organizations, including President of the American Academy of Craniomaxillofacial Surgeons and the American College of Oral and Maxillofacial Surgeons. Amongst his honors, he has been awarded Fellowship in the Royal College of Surgeons of Edinburgh, Ad Hominem.
Disclosure information not submitted.
Monday, October 13, 2025
8:00 AM - 9:00 AM EDT